2026年6月最新影响因子数据已更新，欢迎查询使用。如果您对期刊系统有任何需求或者问题，欢迎反馈给我们。
| 热门AI工具： |
论文引言生成
New
AI 写作痕迹检测
Hot
学术改写降重
论文讨论生成
参考文献挖掘工具
审稿意见辅助撰写
|
查看更多AI工具 >> |
| 近期推荐： | 热 全流程投稿协助套餐服务 | 热 SCI论文AI润色+人工QC服务 | 热 Springer Nature特刊征稿 |
 |
| 基本信息 | 登录收藏 | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名字 | Molecular Therapy Nucleic Acids MOL THER NUCL ACIDS （此期刊被最新的JCR期刊SCIE收录） LetPub评分 7.5
55人评分
我要评分
声誉 8.1 影响力 6.6 速度 9.2 | |||||||||||||||||||||
| 期刊ISSN | 2162-2531 | 安装APP，查看期刊最新消息
| ||||||||||||||||||||
| 2025-2026最新IF （数据来源于网友提供） | 注册或登录后，查看IF | |||||||||||||||||||||
| 实时影响因子 | - | |||||||||||||||||||||
| 2025-2026自引率 | 4.6%点击查看自引率趋势图 | |||||||||||||||||||||
| 五年IF （数据来源于网友提供） | 6.204数据由网友[neonrain285]收集提供 | |||||||||||||||||||||
| h-index | 43 | |||||||||||||||||||||
| CiteScore （ 2026年6月最新版） |
| |||||||||||||||||||||
| 期刊简介 |
| |||||||||||||||||||||
| 期刊官方网站 | http://www.nature.com/mtna/index.html | |||||||||||||||||||||
期刊投稿格式模板 VIP专享 |
| |||||||||||||||||||||
| 期刊投稿网址 | http://mts-mtna.nature.com/cgi-bin/main.plex | |||||||||||||||||||||
| 该期刊中国学者近期发文 - New | Fast activity prediction of chemically modified siRNAs via structure-based energy calculations and inference-augmented tabular deep learning Author: Tan, Wenchong; Dong, Yiheng; Shi, Yuanfang; Chen, Nanwen; Ye, Shimin; Zhang, Heng; Chen, Ping; Zuo, Yinglin; Du, Hongli Journal: MOLECULAR THERAPY NUCLEIC ACIDS. 2026; Vol. 37, Issue 3, pp. -. DOI: 10.1016/j.omtn.2026.103029 A scalable platform for dumbbell siRNA production using engineered Td PIE in probiotic E. coli Author: Huang, Zhibo; Wang, Shaojiao; Liu, Jinhao; Lin, Yude; Xiao, Zhiwei; Chen, Tienan; Shi, Bo; Gu, Sijie; Zhou, Rujiang; Yao, Zhengju; Guo, Xizhi Journal: MOLECULAR THERAPY NUCLEIC ACIDS. 2026; Vol. 37, Issue 3, pp. -. DOI: 10.1016/j.omtn.2026.103030 Targeted FcRn to deliver epitope-optimized RBD confers broad-spectrum mucosal protection against SARS-CoV-2 Author: Chen, Xinlan; Wu, Yan; Wang, Yanhai; Zhao, Chenshu; Fang, Lijuan; Zhu, Xuerui; Lu, Jia; Gao, Xiao; Zhang, Zhongfa; Li, Haoyu; Yan, Yingrui; Zhou, Pengfei; Pan, Xiaoyan Journal: MOLECULAR THERAPY NUCLEIC ACIDS. 2026; Vol. 37, Issue 3, pp. -. DOI: 10.1016/j.omtn.2026.103041 An antisense oligonucleotide targeting STK25 as a long-acting therapeutic candidate for early MASLD Author: Dong, Ao; Li, Na; Lang, Xiping; Chen, Shunkai; Qin, Yifeng; Wang, Yuhang; Wang, Haisheng; Guo, Miaomiao; Yan, Aomei; Song, Kai; Bi, Jingyi; Ren, Guiping; Lai, Fan; Yang, Juan; Dang, Yunkun Journal: MOLECULAR THERAPY NUCLEIC ACIDS. 2026; Vol. 37, Issue 3, pp. -. DOI: 10.1016/j.omtn.2026.103038 | |||||||||||||||||||||
| 期刊语言要求 | 经LetPub语言功底雄厚的美籍native English speaker精心编辑的稿件，不仅能满足Molecular Therapy Nucleic Acids的语言要求，还能让Molecular Therapy Nucleic Acids编辑和审稿人得到更好的审稿体验，让稿件最大限度地被Molecular Therapy Nucleic Acids编辑和审稿人充分理解和公正评估。LetPub的专业SCI论文编辑服务（包括SCI论文英语润色，同行资深专家修改润色，SCI论文专业翻译，SCI论文格式排版，专业学术制图等）帮助作者准备稿件，已助力全球15万+作者顺利发表论文。部分发表范例可查看：服务好评 论文致谢（3篇） 。
提交文稿 | |||||||||||||||||||||
| 是否OA开放访问 | Yes | |||||||||||||||||||||
OA期刊相关信息 | 文章处理费：需要（ USD3900; ） 文章处理费豁免：查看说明 其他费用：没有 期刊主题关键词：vector development、rna based therapeutics、gene modifying agents 相关链接：Aims & ScopeAuthor InstructionsEditorial BoardAnonymous peer review | |||||||||||||||||||||
| 通讯方式 | 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, USA, MA, 02139 | |||||||||||||||||||||
| 出版商 | Cell Press | |||||||||||||||||||||
| 涉及的研究方向 | MEDICINE, RESEARCH & EXPERIMENTAL- | |||||||||||||||||||||
| 出版国家或地区 | UNITED STATES | |||||||||||||||||||||
| 出版语言 | English | |||||||||||||||||||||
| 出版周期 | ||||||||||||||||||||||
| 出版年份 | 0 | |||||||||||||||||||||
| 年文章数 | 280点击查看年文章数趋势图 | |||||||||||||||||||||
| Gold OA文章占比 | 100.00% | |||||||||||||||||||||
| 研究类文章占比： 文章 ÷（文章 + 综述） | 84.64% | |||||||||||||||||||||
| WOS期刊JCR分区 （ 2025-2026年最新版） | 注册或登录后，查看WOS分区等级 | |||||||||||||||||||||
| 期刊分区表预警名单 | 2026年03月发布的新锐学术版：不在预警名单中 2025年03月发布的2025版：不在预警名单中 2024年02月发布的2024版：不在预警名单中 2023年01月发布的2023版：不在预警名单中 2021年12月发布的2021版：预警等级：高 2020年12月发布的2020版：不在预警名单中 | |||||||||||||||||||||
  | ||||||||||||||||||||||
| 《新锐期刊分区表》 （ 2026年3月发布） | 点击查看期刊分区表趋势图
| |||||||||||||||||||||
| 期刊分区表 （ 2025年3月升级版） |
| |||||||||||||||||||||
| 期刊分区表 （ 2023年12月旧的升级版） |
| |||||||||||||||||||||
| SCI期刊收录coverage | Science Citation Index Expanded (SCIE) (2020年1月，原SCI撤销合并入SCIE，统称SCIE) Scopus (CiteScore) Directory of Open Access Journals (DOAJ) 中科院的全球OA期刊索引（OAJ） | |||||||||||||||||||||
| PubMed Central (PMC)链接 | http://www.ncbi.nlm.nih.gov/nlmcatalog?term=2162-2531%5BISSN%5D | |||||||||||||||||||||
| 平均审稿速度 | 网友分享经验： 20 Weeks | |||||||||||||||||||||
| 平均录用比例 | 网友分享经验： | |||||||||||||||||||||
| 版面费/APC文章处理费信息 | 文章处理费：需要（ USD3900; ） 文章处理费豁免：查看说明 其他费用：没有 LetPub提供文章处理费（APC）支持服务，可以用人民币支付版面费啦！ | |||||||||||||||||||||
| LetPub助力发表 | 经LetPub编辑的稿件平均录用比例是未经润色的稿件的1.5倍，平均审稿时间缩短40%。众多作者在使用LetPub的专业SCI论文编辑服务（包括SCI论文英语润色，同行资深专家修改润色，SCI论文专业翻译，SCI论文格式排版，专业学术制图等）后论文在Molecular Therapy Nucleic Acids顺利发表。
快看看作者怎么说吧：服务好评 论文致谢（3篇） 。 提交文稿 | |||||||||||||||||||||
| 期刊常用信息链接 |
| |||||||||||||||||||||
|
|
| |
| 中国学者近期发表的论文 | |
| 1. | Fast activity prediction of chemically modified siRNAs via structure-based energy calculations and inference-augmented tabular deep learning Author: Tan, Wenchong; Dong, Yiheng; Shi, Yuanfang; Chen, Nanwen; Ye, Shimin; Zhang, Heng; Chen, Ping; Zuo, Yinglin; Du, Hongli Journal: MOLECULAR THERAPY NUCLEIC ACIDS. 2026; Vol. 37, Issue 3, pp. -. DOI: 10.1016/j.omtn.2026.103029 DOI |
| 2. | A scalable platform for dumbbell siRNA production using engineered Td PIE in probiotic E. coli Author: Huang, Zhibo; Wang, Shaojiao; Liu, Jinhao; Lin, Yude; Xiao, Zhiwei; Chen, Tienan; Shi, Bo; Gu, Sijie; Zhou, Rujiang; Yao, Zhengju; Guo, Xizhi Journal: MOLECULAR THERAPY NUCLEIC ACIDS. 2026; Vol. 37, Issue 3, pp. -. DOI: 10.1016/j.omtn.2026.103030 DOI |
| 3. | Targeted FcRn to deliver epitope-optimized RBD confers broad-spectrum mucosal protection against SARS-CoV-2 Author: Chen, Xinlan; Wu, Yan; Wang, Yanhai; Zhao, Chenshu; Fang, Lijuan; Zhu, Xuerui; Lu, Jia; Gao, Xiao; Zhang, Zhongfa; Li, Haoyu; Yan, Yingrui; Zhou, Pengfei; Pan, Xiaoyan Journal: MOLECULAR THERAPY NUCLEIC ACIDS. 2026; Vol. 37, Issue 3, pp. -. DOI: 10.1016/j.omtn.2026.103041 DOI |
| 4. | An antisense oligonucleotide targeting STK25 as a long-acting therapeutic candidate for early MASLD Author: Dong, Ao; Li, Na; Lang, Xiping; Chen, Shunkai; Qin, Yifeng; Wang, Yuhang; Wang, Haisheng; Guo, Miaomiao; Yan, Aomei; Song, Kai; Bi, Jingyi; Ren, Guiping; Lai, Fan; Yang, Juan; Dang, Yunkun Journal: MOLECULAR THERAPY NUCLEIC ACIDS. 2026; Vol. 37, Issue 3, pp. -. DOI: 10.1016/j.omtn.2026.103038 DOI |
| 5. | Pharmacological readthrough and base editing for ANK1 nonsense mutations in an erythroid model of hereditary spherocytosis Author: Li, Shan; Li, Juan; Shi, Wenjing; Nie, Ziyan; Zhang, Shasha; Ding, Xue; Hu, Jun; Li, Peiqiang; Xie, Xiaodong Journal: MOLECULAR THERAPY NUCLEIC ACIDS. 2026; Vol. 37, Issue 3, pp. -. DOI: 10.1016/j.omtn.2026.103053 DOI |
| 6. | Milk-derived extracellular vesicles loaded with miR-146a-5p as a novel therapeutic strategy for allergic airway inflammation Author: Li, Chan-Gu; Sun, Qi; Tian, Tian; Wu, Zi-Cong; Xie, Ying-Chun; Liu, Xiao-Qing; Zhou, Zhi-Rou; Huang, Long-Xin; Deng, Xiao-Hui; Yu, Si-Lin; Fu, Qing-Ling Journal: MOLECULAR THERAPY NUCLEIC ACIDS. 2026; Vol. 37, Issue 3, pp. -. DOI: 10.1016/j.omtn.2026.102980 PubMed DOI |
| 7. | Decoding preeclampsia: A fusion of multi-view machine learning and multi-omics to identify putative inflammation-related mechanisms Author: Guo, Yuting; Liang, Yuchao; Liu, Lingxuan; Zhou, Yan; Yang, Xiaoyan; Ming, Xin; Hu, Pengwei; Wu, Jie; Li, Debang; Hou, Dongxia; Xia, Shuqin; Wang, Xiaohua; Zuo, Yongchun Journal: MOLECULAR THERAPY NUCLEIC ACIDS. 2026; Vol. 37, Issue 3, pp. -. DOI: 10.1016/j.omtn.2026.102992 PubMed DOI |
| 8. | Y-RNAs and their fragments reflect kidney injury in diabetic kidney disease Author: Zhao, Qiao; Liang, Yunyi; Postma, Rudmer; Duijs, Jacques M. G. J.; de Klerk, Juliette A.; 't Hart, Leen M.; Rotmans, Joris I.; van Zonneveld, Anton Jan; Bijkerk, Roel Journal: MOLECULAR THERAPY NUCLEIC ACIDS. 2026; Vol. 37, Issue 3, pp. -. DOI: 10.1016/j.omtn.2026.102998 PubMed DOI |
| 9. | Evaluation and forecasting of siRNA delivery technologies: An analysis of hierarchical decision model based on patent data Author: Chen, Shiyun; Peng, Yixuan; Yan, Dilei; Lyu, Liyang; Scherngell, Thomas; Hu, Yuanjia Journal: MOLECULAR THERAPY NUCLEIC ACIDS. 2026; Vol. 37, Issue 2, pp. -. DOI: 10.1016/j.omtn.2026.102943 PubMed DOI |
| 10. | BRPtools: An AutoML-Powered web platform for multiclass disease prediction from bulk blood RNA-seq data Author: Guo, Yichen; Yang, Fengyuan; Zhang, Xuelu; Zhai, Zhaoyu; Pan, Jianbo Journal: MOLECULAR THERAPY NUCLEIC ACIDS. 2026; Vol. 37, Issue 2, pp. -. DOI: 10.1016/j.omtn.2026.102956 PubMed DOI |
|
|
  | ||||||||||||||||
|
投稿状态统计： 我要评分： | ||||||||||||||||
| 投稿前担心稿件结构或语言不够规范？试试稿件自查工具，一键检测 >> | ||||||||||||||||
|
||||||||||||||||
同领域作者分享投稿经验：共411条 |
||||||||||||||||
|
|
联系我们 | 站点地图 | 友情链接 | 授权代理商 | 加入我们
© 2010-2026 中国: LetPub上海 网站备案号：沪ICP备10217908号-1 
沪公网安备号：31010402006960 （网站）31010405000484 （蝌蝌APP）
增值电信业务经营许可证：沪B2-20211595 网络文化经营许可证：沪网文[2023]2004-152号
礼翰商务信息咨询（上海）有限公司 办公地址：上海市徐汇区漕溪北路88号圣爱大厦1803室
安全保密
投稿信 (Cover Letter) 模板
